AeroMed, Inc. of Amsterdam, New York makes equipment for the control of airborne infectious diseases such as tuberculosis and COVID-19. Bill Palmer, the company’s founder, has designed numerous products that use either high-efficiency particulate air (HEPA) filters or germicidal ultraviolet light (GUV). Today, AeroMed supplies upper-room GUV systems, HEPA air purification equipment, aerosol treatment chambers, and room pressure monitors. A global business, the Mohawk Valley manufacturer has partners in India and Africa with installed systems in Vietnam, Pakistan, and many other countries.
Before COVID-19, AeroMed’s equipment was used mainly in the fight against tuberculosis (TB), an airborne infectious disease that is rare in the United States but that kills thousands of people a day around the world. COVID-19 is viral rather than bacterial, but the TB bacterium is like the COVID-19 virus in that both microorganisms are spread when an infected person coughs or sneezes. Moreover, some people who are infected with TB or COVID-19 remain asymptomatic – meaning that they do not display symptoms. U.S. hospitals see relatively few TB patients, but COVID-19’s burden on healthcare everywhere is well-known.
When FuzeHub learned that AeroMed was pivoting during the COVID-19 pandemic, we invited Bill Palmer to join us for a podcast. Bill is currently working 15-hour days, but graciously took the time to talk to us about how his New York State manufacturing company is meeting demand and making a difference. Click play below to listen to FuzeHub’s interview with AeroMed’s Bill Palmer.
